Supplementary Figure from A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma

Míreanna comhchosúla

• Supplementary Figure from A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma
  de réir: Weijia Cai (15099353)
  Foilsithe / Cruthaithe: (2025)
• Supplementary Figure from A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma
  de réir: Weijia Cai (15099353)
  Foilsithe / Cruthaithe: (2025)
• Supplementary Figure from A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma
  de réir: Weijia Cai (15099353)
  Foilsithe / Cruthaithe: (2025)
• Supplementary Figure from A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma
  de réir: Weijia Cai (15099353)
  Foilsithe / Cruthaithe: (2025)
• Supplementary Table from A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in <i>NRAS</i> Mutant Melanoma
  de réir: Weijia Cai (15099353)
  Foilsithe / Cruthaithe: (2025)